During the last session, Journey Medical Corp (NASDAQ:DERM)’s traded shares were 0.37 million, with the beta value of the company hitting 0.92. At the end of the trading day, the stock’s price was $6.17, reflecting an intraday gain of 7.30% or $0.42. The 52-week high for the DERM share is $8.11, that puts it down -31.44 from that peak though still a striking 53.81% gain since the share price plummeted to a 52-week low of $2.85. The company’s market capitalization is $127.89M, and the average intraday trading volume over the past 10 days was 0.1 million shares, and the average trade volume was 65.42K shares over the past three months.
Journey Medical Corp (DERM) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. DERM has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.15.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Journey Medical Corp (NASDAQ:DERM) trade information
Journey Medical Corp (DERM) registered a 7.30% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 7.30% in intraday trading to $6.17, hitting a weekly high. The stock’s 5-day price performance is 7.12%, and it has moved by -1.91% in 30 days. Based on these gigs, the overall price performance for the year is 78.84%. The short interest in Journey Medical Corp (NASDAQ:DERM) is 76691.0 shares and it means that shorts have 1.28 day(s) to cover.
Journey Medical Corp (DERM) estimates and forecasts
Statistics show that Journey Medical Corp has underperformed its competitors in share price, compared to the industry in which it operates. Journey Medical Corp (DERM) shares have gone up 67.21% during the last six months, with a year-to-date growth rate less than the industry average at -400.00% against 18.10. Yet analysts are ramping up their growth forecast for the fiscal year 2024. Revenue is predicted to shrink -118.80% this quarter and then drop -25.00% in the quarter after that. In the rating firms’ projections, revenue will decrease -27.90% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 14.46M as predicted by 4 analyst(s). Meanwhile, a consensus of 4 analyst(s) estimates revenue growth to 14.75M by the end of current fiscal year.
While earnings are projected to return -408.57% in 2024.
DERM Dividends
Journey Medical Corp is due to release its next quarterly earnings on 2024-Aug-12. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Journey Medical Corp (NASDAQ:DERM)’s Major holders
Journey Medical Corp insiders own 30.81% of total outstanding shares while institutional holders control 16.29%, with the float percentage being 23.54%. VANGUARD GROUP INC is the largest shareholder of the company, while 41.0 institutions own stock in it. As of 2024-06-30, the company held over 0.31 million shares (or 1.5703% of all shares), a total value of $1.75 million in shares.
The next largest institutional holding, with 0.29 million shares, is of CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC.’s that is approximately 1.4929% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $1.66 million.
